Health Care & Life Sciences » Biotechnology | AMAG Pharmaceuticals Inc.

AMAG Pharmaceuticals Inc.

AMAG Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$6.4
Market Cap
$337.67 M
Shares Outstanding
33.77 M
Public Float
33.53 M

Profile

Address
1100 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.amagpharma.com
Updated 07/08/2019
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases.

Financials

View All

William K. Heiden
President, Chief Executive Officer & Director
Gino Santini
Chairman